Publication | Closed Access
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study
43
Citations
18
References
2014
Year
ClinicalTrials.gov identifier NCT00977080.
| Year | Citations | |
|---|---|---|
Page 1
Page 1